Platinum-based adjuvant therapy was efficient for triple-negative breast cancer: a meta-analysis from randomized controlled trials

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer. Neoadjuvant chemotherapy was widely accepted for treating TNBC. This systematic review and meta-analysis aimed to evaluate the efficacy, safety, and survival benefit of platinum-based adjuvant therapy (PBAT) in treating TNBC....

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Kaigang, Ren, Xuanlei, Hong, Xiaoming, Zhu, Shuiyin, Wang, Dongjie, Ye, Xiaoming, Ren, Xiaoting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601551/
https://www.ncbi.nlm.nih.gov/pubmed/36278891
http://dx.doi.org/10.1080/21655979.2022.2115616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601551/
https://www.ncbi.nlm.nih.gov/pubmed/36278891
http://dx.doi.org/10.1080/21655979.2022.2115616

Ejemplares similares